SAPHO Syndrome

Rheumatic Disease Clinics of North America

Volumn 39, Issue 2, 2013, Pages 401-418

  Carneiro, Sueli ^a,b   Sampaio Barros, Percival D ^c  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Acne conglobata; Chronic recurrent multifocal osteomyelitis; Hyperostosis; Pustulosis palmoplantaris; SAPHO; Therapy

Indexed keywords

ADALIMUMAB; ALENDRONIC ACID; ANALGESIC AGENT; ANTIBIOTIC AGENT; AZITHROMYCIN; BIOLOGICAL PRODUCT; BISPHOSPHONIC ACID DERIVATIVE; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CLINDAMYCIN; CORTICOSTEROID; DOXYCYCLINE; ETANERCEPT; HLA B27 ANTIGEN; HLA B51 ANTIGEN; HLA B52 ANTIGEN; IBANDRONIC ACID; INFLIXIMAB; ISOTRETINOIN; LEFLUNOMIDE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PAMIDRONIC ACID; PROTEIN P53; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RISEDRONIC ACID; SALAZOSULFAPYRIDINE; ZOLEDRONIC ACID;

ABSENCE OF SIDE EFFECTS; ACNE; BONE DISEASE; BONE RADIOGRAPHY; BONE SCINTISCANNING; CARD15 GENE; CLINICAL EXAMINATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; ECHOGRAPHY; GENE; GENE FREQUENCY; HEREDITY; HUMAN; HYPEROSTOSIS; IMMUNOPATHOLOGY; INFECTION; INFLAMMATORY DISEASE; MUSCLE WEAKNESS; NOD2 GENE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEITIS; OSTEOARTHROPATHY; PLASTIC SURGERY; PREVALENCE; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; PSTPIP2 GENE; PUSTULOSIS; REVIEW; SAPHO SYNDROME; SKIN DISEASE; SPONDYLARTHRITIS; TONIC CLONIC SEIZURE;

ACNE VULGARIS; ACQUIRED HYPEROSTOSIS SYNDROME; ARTHRALGIA; CAUSALITY; HUMANS; HYPEROSTOSIS; JOINTS; MUSCULOSKELETAL DISEASES; MUSCULOSKELETAL PAIN; OSTEITIS; RARE DISEASES; SKIN; SYNOVITIS;

EID: 84876696551     PISSN: 0889857X     EISSN: 15583163     Source Type: Journal    
DOI: 10.1016/j.rdc.2013.02.009     Document Type: Review

References (107)

1. Chamot A.M., Benhamou C.L., Khan M.F., et al. Le syndrome acné pustulose hyperostose ostéite. Résultats d'une enquête nationale; 85 observations. Rev Rhum Mal Osteoartic 1987, 54:187-196. [in French].
2. Benhamou C.L., Chamot A.M., Kahn M.F. Synovitis-acne-pustulosis-hyperostosis-osteomyelitis syndrome (SAPHO) A new syndrome among the spondyloarthropathies?. Clin Exp Rheumatol 1988, 6(2):109-112.
3. Kahn M.F., Khan M.A. The SAPHO syndrome. Baillieres Clin Rheumatol 1994, 8(2):333-362.
4. Beretta-Picolli B.C., Sauvin M.J., Gal I., et al. Synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome: a report of ten cases and review of the literature. Eur J Pediatr 2000, 159(8):594-601.
5. Colina M., Govoni M., Orzincolo C., et al. Clinical and radiologic evolution of synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: a single center study of a cohort of 71 patients. Arthritis Rheum 2009, 61(6):813-821.
6. Nguyen M.T., Borchers A., Selmi C., et al. The SAPHO syndrome. Semin Arthritis Rheum 2012, 42(3):254-265.
7. Hayem G., Bouchaud-Chabot A., Benali K., et al. SAPHO syndrome: a long-term follow-up study of 120 cases. Semin Arthritis Rheum 1999, 29(3):159-171.
8. Sallés M., Olivé A., Perez-Andres R., et al. The SAPHO syndrome: a clinical and imaging study. Clin Rheumatol 2011, 30(2):245-249.
9. Zhao Z., Li Y., Li Y., et al. Synovitis, acne, pustulosis, hyperostosis and osteitis (SAPHO) syndrome with review of the relevant published work. J Dermatol 2011, 38(2):155-159.
10. Van Doornum S., Baraclough D., McColl G., et al. SAPHO: rare or just not recognized?. Semin Arthritis Rheum 2000, 30(1):70-77.
11. Steinhoff J.P., Cilursu A., Falasca G.F., et al. A study of musculoskeletal manifestations in 12 patients with SAPHO syndrome. J Clin Rheumatol 2002, 8(1):13-22.
12. Grosjean C., Hurtado-Nedelec M., Nicaise-Roland P., et al. Prevalence of autoantibodies in SAPHO syndrome: a single-center study of 90 patients. J Rheumatol 2010, 37(3):639-643.
13. Maugars Y., Berthelot J.M., Ducloux J.M., et al. SAPHO syndrome: a followup study of 19 cases with special emphasis on enthesis involvement. J Rheumatol 1995, 22(11):2135-2141.
14. McPhillips A., Wolford L.M., Rodrigues D.B. SAPHO syndrome with TMJ involvement: review of the literature and case presentation. Int J Oral Maxillofac Surg 2010, 39(12):1160-1167.
15. Earwaker J.W., Cotten A. SAPHO: syndrome or concept? Imaging findings. Skeletal Radiol 2003, 32(6):311-327.
16. Tlougan B.E., Podjasek J.O., O'Haver J., et al. Chronic recurrent multifocal osteomyelitis (CRMO) and synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome with associated neutrophilic dermatoses: a report of seven cases and review of the literature. Pediatr Dermatol 2009, 26(5):497-505.
17. Wipff J., Adamsbaum C., Kahan A., et al. Chronic recurrent multifocal osteomyelitis. Joint Bone Spine 2011, 78(6):555-560.
18. Abul-Kasim K., Nilsson T., Turesson C. Intracranial manifestations in SAPHO syndrome: the first case report in literature. Rheumatol Int 2012, 32(6):1797-1799.
19. Legoupil N., Révelon G., Allain J., et al. Iliac vein thrombosis complicating SAPHO syndrome: MRI and histologic features of soft tissue lesions. Joint Bone Spine 2001, 68(1):79-83.
20. Kawabata T., Morita Y., Nakatsuka A., et al. Multiple venous thrombosis in SAPHO syndrome. Ann Rheum Dis 2005, 64(3):505-506.
21. Smith M., Buller A., Radford R., et al. Ocular presentation of the SAPHO syndrome. Br J Ophthalmol 2005, 89(8):1069-1070.
22. Mann B., Shaerf D.A., Sheeraz A., et al. SAPHO syndrome presenting as widespread bony metastatic disease of unknown origin. Rheumatol Int 2012, 32(2):505-507.
23. Queiro R., Moreno P., Sarasqueta C., et al. Synovitis-acne-pustulosis-hyperostosis-osteitis syndrome and psoriatic arthritis exhibit a different immunogenetic profile. Clin Exp Rheumatol 2008, 26(1):125-128.
24. Akisue T., Yamamoto T., Marui T., et al. Lumbar spondylodiscitis in SAPHO syndrome: multimodality imaging findings. J Rheumatol 2002, 29(5):1100-1101.
25. Tohme-Noun C., Feydy A., Belmatoug N., et al. Cervical involvement in SAPHO syndrome: imaging findings with a 10-year follow-up. Skeletal Radiol 2003, 32(2):103-106.
26. Depasquale R., Kumar N., Lalam R.K., et al. SAPHO: what radiologists should know. Clin Radiol 2012, 67(3):195-206.
27. Queiro R., Alonso S., Alperi M., et al. Entheseal ultrasound abnormalities in patients with SAPHO syndrome. Clin Rheumatol 2012, 31(6):913-919.
28. Freyschmidt J., Sternberg A. The bullhead sign: scintigraphic pattern of sternocostoclavicular hyperostosis and pustulotic arthroosteitis. Eur Radiol 1998, 8:807-812.
29. Guglielmi G., Cascavilla A., Scalzo G., et al. Imaging of sternocostoclavicular joint in spondyloarthropathies and other rheumatic conditions. Clin Exp Rheumatol 2009, 27(3):402-408.
30. Patel C.N., Smith J.T., Rankine J.J., et al. F18 FDG PET/CT can help differentiate SAPHO syndrome from suspected metastatic bone disease. Clin Nucl Med 2009, 34(4):254-257.
31. Laredo J.V., Vuillemin-Bodaghi V., Butry N., et al. SAPHO syndrome: MR appearance of vertebral involvement. Radiology 2007, 242(3):825-831.
32. Chen W., Obermayer-Pietsch B., Hong J.B., et al. Acne-associated syndromes: models for better understanding of acne pathogenesis. J Eur Acad Dermatol Venereol 2011, 25(6):637-646.
33. Lindor N.M., Arsenault T.M., Solomon H., et al. A new autosomal dominant disorder of pyogenic sterile arthritis, pyoderma gangrenosum, and acne: PAPA syndrome. Mayo Clin Proc 1997, 72(7):611-615.
34. Braun-Falco M., Kovnerystyy O., Lohse P., et al. Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH)-a new autoinflammatory syndrome distinct from PAPA syndrome. J Am Acad Dermatol 2012, 66(3):409-415.
35. Bhalla R., Sequeira W. Arthritis associated with hidradenitis suppurativa. Ann Rheum Dis 1994, 53(1):64-66.
36. Olafsson F., Khan M.A. Musculoskeletal features of acne, hidradenitis suppurativa, and dissecting cellulitis of the scalp. Rheum Dis Clin North Am 1992, 18(1):215-224.
37. Diri E., Mat C., Hamuryudan V., et al. Papulopustular skin lesions are seen more frequently in patients with Behçet's syndrome who have arthritis: a controlled and masked study. Ann Rheum Dis 2001, 60(11):1074-1076.
38. Elkayam O., Yaron M., Caspi D. Minocycline-induced autoimmune syndromes: an overview. Semin Arthritis Rheum 1999, 28(6):392-397.
39. Goulden V., Layton A.M., Cunliffe W.J. Long-term safety of isotretinoin as a treatment for acne vulgaris. Br J Dermatol 1994, 131(3):360-363.
40. Scarpa R., Lubrano E., Cozzi R., et al. Subcorneal pustular dermatosis (Sneddon-Wilkinson syndrome): another cutaneous manifestation of SAPHO syndrome?. Br J Rheumatol 1997, 36(5):602-603.
41. Hyodoh K., Sugimoto H. Pustulotic arthro-osteitis: defining the radiologic spectrum of the disease. Semin Musculoskelet Radiol 2001, 5(2):89-93.
42. Dihlmann W., Schnabel A., Gross W.L. The acquired hyperostosis syndrome: a little known skeletal disorder with distinctive radiological and clinical features. Clin Investig 1993, 72(1):4-11.
43. Giedion A., Holthusen W., Masel L.F., et al. Subacute and chronic " symmetrical" osteomyelitis. Ann Radiol (Paris) 1972, 15(3):329-342. [in Multiple languages].
44. Zemann W., Pau M., Feichtinger M., et al. SAPHO syndrome with affection of the mandible: diagnosis, treatment, and review of literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011, 111(2):190-195.
45. Ferguson P.J., Chen S., Tayeh M.K., et al. Homozygous mutations in LPIN2 are responsible for the syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia (Majeed syndrome). J Med Genet 2005, 42(7):551-557.
46. Gikas P.D., Islam L., Aston W., et al. Nonbacterial osteitis: a clinical, histopathological, and imaging study with a proposal for protocol-based management of patients with this diagnosis. J Orthop Sci 2009, 14(5):505-516.
47. Nakamura J., Yamada K., Mitsugi N., et al. A case of SAPHO syndrome with destructive spondylodiscitis suspicious of tuberculous spondylitis. Mod Rheumatol 2010, 20(1):93-97.
48. Arnson Y., Rubinow A., Amital H. Secondary syphilis presenting as SAPHO syndrome features. Clin Exp Rheumatol 2008, 26(6):1119-1121.
49. Windom R.E., Sanford J.P., Ziff M. Acne conglobata and arthritis. Arthritis Rheum 1961, 4:632-635.
50. Hurtado-Nedelec M., Chollet-Martin S., Chapeton D., et al. Genetic susceptibility factors in a cohort of 38 patients with SAPHO syndrome: a study of PSTPIP2, NOD2, and LPIN2 genes. J Rheumatol 2010, 37(2):401-409.
51. Suei Y., Taguchi A., Tanimoto K. Diagnostic points and possible origin of osteomyelitis in synovitis, acne, pustulosis, hyperostosis and osteitis (SAPHO) syndrome: a radiographic study of 77 mandibular osteomyelitis cases. Rheumatology (Oxford) 2003, 42:1398-1403.
52. Twilt M., Laxer R.M. Clinical care of children with sterile bone inflammation. Curr Opin Rheumatol 2011, 23(5):424-431.
53. Assmann G., Simon P. The SAPHO syndrome-are microbes involved. Best Pract Res Clin Rheumatol 2011, 25(3):423-434.
54. Govoni M., Colina M., Massara A., et al. SAPHO syndrome and infections. Autoimmun Rev 2009, 8(3):256-259.
55. Perry A., Lambert P. Propionibacterium acnes: infection beyond the skin. Expert Rev Anti Infect Ther 2011, 9(12):1149-1156.
56. Kotilainen P., Merilahti-Palo R., Lehtonen O.P., et al. Propionibacterium acnes isolated from sternal osteitis in a patient with SAPHO syndrome. J Rheumatol 1996, 23(7):1302-1304.
57. Magrey M., Khan M.A. New insights into synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome. Curr Rheumatol Rep 2009, 11(5):329-333.
58. Trimble B.S., Evers C.J., Ballaron A.S., et al. Intraarticular injection of Propionibacterium acnes causes an erosive arthritis in rats. Agents Actions 1987, 21(3-4):281-283.
59. Kirchhoff T., Merkesdal S., Rosenthal H., et al. Diagnostic management of patients with SAPHO syndrome: use of MRI imaging to guide bone biopsy at CT for microbiological and histological work-up. Eur Radiol 2003, 13:2304-2308.
60. Kallis C., Gumenscheimer M., Freudenberg N., et al. Requirement for TLR9 in the immunomodulatory activity of Propionibacterium acnes. J Immunol 2005, 174(7):4295-4300.
61. Hayem G. Valuable lessons from SAPHO syndrome. Joint Bone Spine 2007, 74(2):123-126. [editorial].
62. Hurtado-Nedelec M., Chollet-Martin S., Nicaise-Roland P., et al. Characterization of the immune response in the Synovitis, Acne, Pustulosis, Hyperostosis, Osteitis (SAPHO) syndrome. Rheumatology (Oxford) 2008, 47:1160-1167.
63. Matsumaru K., Nagai K., Murakami T., et al. SAPHO syndrome with bacillus Calmette-Guerin (BCG) immunotherapy for bladder cancer. BMJ Case Rep 2010, 2010:2591.
64. Ben Abdelghani K., Dran D.G., Gottenberg J.E., et al. Tumor necrosis factor-alpha blockers in SAPHO syndrome. J Rheumatol 2010, 37(8):1699-1704.
65. Burgemeister L.T., Baeten D.L., Tas S.W. Biologics for rare inflammatory diseases: TNF blockade in the SAPHO syndrome. Neth J Med 2012, 70(10):444-449.
66. Garcovich S., Amelia R., Magarelli N., et al. Long-term treatment of severe SAPHO syndrome with adalimumab: case report and a review of the literature. Am J Clin Dermatol 2012, 13(1):55-59.
67. Colina M., Pizzirani C., Khodeir M., et al. Dysregulation of P2X7 receptor-inflammasome axis in SAPHO syndrome: successful treatment with anakinra. Rheumatology (Oxford) 2010, 49(7):1416-1418.
68. Marzo-Ortega H., Baxter K., Strauss R.M., et al. Is minocycline therapy in acne associated with antineutrophil cytoplasmic antibody positivity? A cross-sectional study. Br J Dermatol 2007, 156(5):1005-1009.
69. Darley C.R., Currey H.L., Baker H. Acne fulminans with arthritis in identical twins treated with isotretinoin. J R Soc Med 1984, 77:328-330.
70. Dumolard A., Gaudin P., Juvin R., et al. SAPHO syndrome or psoriatic arthritis? A familial case study. Rheumatology (Oxford) 1999, 38(5):463-467.
71. Gonzalez T., Gantes M., Bustabad S., et al. Acne fulminans associated with arthritis in monozygotic twins. J Rheumatol 1985, 12(2):389-391.
72. Yabe H., Ohshima H., Takano Y., et al. Mucosal lesions may be a minor complication of SAPHO syndrome: a study of 11 Japanese patients with SAPHO syndrome. Rheumatol Int 2010, 30(10):1277-1283.
73. Byrd L., Grossmann M., Potter M., et al. Chronic multifocal osteomyelitis, a new recessive mutation on chromosome 18 of the mouse. Genomics 1991, 11(4):794-798.
74. Ferguson P.J., Bing X., Vasef M.A., et al. A missense mutation in pstpip2 is associated with the murine autoinflammatory disorder chronic multifocal osteomyelitis. Bone 2006, 38(1):41-47.
75. Baum W., Kirkin V., Fernandez S.B., et al. Binding of the intracellular Fas ligand (FasL) domain to the adaptor protein PSTPIP results in a cytoplasmic localization of FasL. J Biol Chem 2005, 280(48):40012-40024.
76. Golla A., Jansson A., Ramser J., et al. Chronic recurrent multifocal osteomyelitis (CRMO): evidence for a susceptibility gene located on chromosome 18q21.3-18q22. Eur J Hum Genet 2002, 10(3):217-221.
77. Assmann G., Wagner A.D., Monika M., et al. Single-nucleotide polymorphisms p53 G72C and Mdm2 T309G in patients with psoriasis, psoriatic arthritis, and SAPHO syndrome. Rheumatol Int 2010, 30(10):1273-1276.
78. Yeon H.B., Lindor N.M., Seidman J.G., et al. Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome maps to chromosome 15q. Am J Hum Genet 2000, 66(4):1443-1448.
79. Wise C., Gillum J., Seidman C., et al. Mutations in CD2BP1 disrupt binding to PTP PEST and are responsible for PAPA syndrome, an autoinflammatory disorder. Hum Mol Genet 2002, 11(8):961-969.
80. Hampe J., Grebe J., Nikolaus S., et al. Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort study. Lancet 2002, 359:1661-1665.
81. Giardin S.E., Boneca I.G., Viala J., et al. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 2003, 278(11):8869-8872.
82. Olivieri I., Padula A., Palazzi C. Pharmacological management of SAPHO syndrome. Expert Opin Investig Drugs 2006, 15(10):1229-1233.
83. Jung J., Molinger M., Kohn D., et al. Intra-articular glucocorticosteroid injection into sternocostoclavicular joints in patients with SAPHO syndrome. Semin Arthritis Rheum 2012, 42(3):266-270.
84. Assmann G., Kueck O., Kirchhoff T., et al. Efficacy of antibiotic therapy for SAPHO syndrome is lost after its discontinuation: an interventional study. Arthritis Res Ther 2009, 11(5):R140.
85. Azevedo V.F., Dal Pizzol V.I., Lopes H., et al. Methotrexate to treat SAPHO syndrome with keloidal scars. Acta Reumatol Port 2011, 36(2):167-170. [in Portuguese].
86. Scarpato S., Tirri E. Successful treatment of SAPHO syndrome with leflunomide. Report of two cases. Clin Exp Rheumatol 2005, 23(5):731.
87. Eleftheriou D., Gerschman T., Sebire N., et al. Biologic therapy in refractory chronic non-bacterial osteomyelitis of childhood. Rheumatology (Oxford) 2010, 49(8):1505-1512.
88. De Souza A., Solomon G.E., Strober B.E. SAPHO syndrome associated with hidradenitis suppurativa successfully treated with infliximab and methotrexate. Bull NYU Hosp Jt Dis 2011, 69(2):185-187.
89. Vilar-Alejo J., Dehesa L., de la Rosa-del Rey P., et al. SAPHO syndrome with unusual cutaneous manifestations treated successfully with etanercept. Acta Derm Venereol 2010, 90(5):531-532.
90. Arias-Santiago S., Sanchez-Cano D., Callejas-Rubio J.L., et al. Adalimumab treatment for SAPHO syndrome. Acta Derm Venereol 2010, 90(3):301-302.
91. Castelví I., Bonet M., Narváez J.A., et al. Successful treatment of SAPHO syndrome with adalimumab: a case report. Clin Rheumatol 2010, 29(10):1205-1207.
92. Pazyar N., Feily A., Yaghoobi R. An overview of interleukin-1 receptor antagonist, anakinra, in the treatment of cutaneous diseases. Curr Clin Pharmacol 2012, 7(4):271-275.
93. Wendling D., Prati C., Aubin F. Anakinra treatment of SAPHO syndrome: short-term results of an open study. Ann Rheum Dis 2012, 71(6):1098-1100.
94. Fioravanti A., Cantarini L., Burroni L., et al. Efficacy of alendronate in the treatment of the SAPHO syndrome. J Clin Rheumatol 2008, 14(3):183-184.
95. Soyfoo M.S., Gangji V., Margaux J. Successful treatment of SAPHO syndrome with ibandronate. J Clin Rheumatol 2010, 16(5):253.
96. Courtney P.A., Hosking D.J., Fairbairn K.J., et al. Treatment of SAPHO with pamidronate. Rheumatology (Oxford) 2002, 41(10):1196-1198.
97. Marshall H., Bromilow J., Thomas A.L., et al. Pamidronate: a novel treatment for the SAPHO syndrome?. Rheumatology (Oxford) 2002, 41(2):231-233.
98. Guignard S., Job-Deslandre C., Sayag-Boukris V., et al. Pamidronate treatment in SAPHO syndrome. Joint Bone Spine 2002, 69(4):392-396.
99. Amital H., Applbaum Y.H., Aamar S., et al. SAPHO syndrome treated with pamidronate: an open-label study of 10 patients. Rheumatology (Oxford) 2004, 43(5):658-661.
100. Colina M., La Corte R., Trotta F. Sustained remission of SAPHO syndrome with pamidronate: a follow-up of fourteen cases and a review of the literature. Clin Exp Rheumatol 2009, 27(1):112-115.
101. Galadari H., Bishop A.G., Venna S.S., et al. Synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome treated with a combination of isotretinoin and pamidronate. J Am Acad Dermatol 2009, 61(1):123-125.
102. Kerrison C., Davidson J.E., Cleary A.G., et al. Pamidronate in the treatment of childhood SAPHO syndrome. Rheumatology (Oxford) 2004, 43(10):1246-1251.
103. Siau K., Laversuch C. SAPHO syndrome in an adult with ulcerative colitis responsive to intravenous pamidronate: a case report and review of the literature. Joint Bone Spine 2010, 30(8):1085-1088.
104. Kopterides P., Pikazis D., Koufos C. Successful treatment of SAPHO syndrome with zoledronic acid. Arthritis Rheum 2004, 50(9):2970-2973.
105. Hatano H., Shigeishi H., Higashikawa K., et al. A case of SAPHO syndrome with diffuse sclerosing osteomyelitis of the mandible treated successfully with prednisolone and bisphosphonate. J Oral Maxillofac Surg 2012, 70(3):626-631.
106. Solau-Gervais E., Soubrier M., Gerot I., et al. The usefulness of bone remodeling markers in predicting the efficacy of pamidronate treatment of SAPHO syndrome. Rheumatology (Oxford) 2006, 45(3):339-342.
107. Takigawa T., Tanaka M., Nakahara S., et al. SAPHO syndrome with rapidly progressing destructive spondylitis: two cases treated surgically. Eur Spine J 2008, 17(Suppl 2):S331-S337.